• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏脂贮积症 II/III 的诊断策略。

Diagnostic strategy for mucolipidosis II/III.

机构信息

FRIGEs Institute of Human Genetics, FRIGE House, Jodhpur Gam Road, Satellite, Ahmedabad. India.

出版信息

Indian Pediatr. 2012 Dec;49(12):975-7. doi: 10.1007/s13312-012-0247-6. Epub 2012 Jun 10.

DOI:10.1007/s13312-012-0247-6
PMID:22728628
Abstract

Overlapping clinical phenotypes are a diagnostic challenge to the clinician, especially in the cases of mucolipidosis (ML) and mucopolysaccharide disorders (MPS), due to overlapping phenotypes. Present study was carried out in 147 children suspected to have ML or MPS and 100 controls. They were screened for ML II/III by colorimetric method using substrate pNCS. Six children were found screen positive for ML II/III and further confirmatory study showed significantly raised activity in plasma confirming high specificity of the ML screening test. Forty-two (28.5%) children out of remaining 141 children that were screen negative, were found to have various MPS disorders, while rest 99 had normal enzyme activity in plasma and leucocytes. Present study demonstrates prompt and specific chemical method that can be used as a tool for estimating ML II/III, with high specificity.

摘要

重叠的临床表型对临床医生来说是一个诊断挑战,特别是在黏脂贮积症 (ML) 和黏多糖贮积症 (MPS) 的情况下,因为它们的表型重叠。本研究在 147 名疑似 ML 或 MPS 的儿童和 100 名对照中进行。他们使用底物 pNCS 通过比色法筛选 ML II/III。发现 6 名儿童 ML II/III 筛查阳性,进一步的确认研究显示血浆中活性显著升高,证实了 ML 筛查试验的高特异性。在剩余的 141 名筛查阴性的儿童中,有 42 名(28.5%)被发现患有各种 MPS 疾病,而其余 99 名儿童的血浆和白细胞中的酶活性正常。本研究表明,这种快速而特异的化学方法可作为估计 ML II/III 的工具,具有很高的特异性。

相似文献

1
Diagnostic strategy for mucolipidosis II/III.黏脂贮积症 II/III 的诊断策略。
Indian Pediatr. 2012 Dec;49(12):975-7. doi: 10.1007/s13312-012-0247-6. Epub 2012 Jun 10.
2
Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses.黏多糖贮积症和黏脂贮积症中的硫酸乙酰肝素水平。
J Inherit Metab Dis. 2005;28(5):743-57. doi: 10.1007/s10545-005-0069-y.
3
Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses.黏多糖贮积症和黏脂贮积症中的硫酸角质素水平。
J Inherit Metab Dis. 2005;28(2):187-202. doi: 10.1007/s10545-005-5673-3.
4
Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry.通过串联质谱法对黏多糖贮积症和黏脂贮积症 II、III 中衍生自硫酸皮肤素和硫酸乙酰肝素的二糖组成进行验证。
Mol Genet Metab. 2010 Feb;99(2):124-31. doi: 10.1016/j.ymgme.2009.10.001. Epub 2009 Oct 12.
5
A Multiplex Assay for the Diagnosis of Mucopolysaccharidoses and Mucolipidoses.一种用于诊断黏多糖贮积症和黏脂贮积症的多重检测方法。
PLoS One. 2015 Sep 25;10(9):e0138622. doi: 10.1371/journal.pone.0138622. eCollection 2015.
6
Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.黏多糖贮积症和黏脂贮积症患者干血斑中的糖胺聚糖水平。
Mol Genet Metab. 2017 Mar;120(3):247-254. doi: 10.1016/j.ymgme.2016.12.010. Epub 2016 Dec 22.
7
I Cell Disease (Mucolipidosis II Alpha/Beta): From Screening to Molecular Diagnosis.I型细胞病(黏脂贮积症II型α/β型):从筛查到分子诊断
Indian J Pediatr. 2017 Feb;84(2):144-146. doi: 10.1007/s12098-016-2243-7. Epub 2016 Oct 27.
8
[Hereditary lysosomal diseases in Mexico. II. Laboratory diagnosis of mucopolysaccharidosis and mucolipidosis].[墨西哥的遗传性溶酶体疾病。II. 黏多糖贮积症和黏脂贮积症的实验室诊断]
Rev Invest Clin. 1990 Jul-Sep;42(3):165-73.
9
Lysosomal Storage Disorders in Indian Children with Neuroregression Attending a Genetic Center.在一家遗传中心就诊的患有神经退行性疾病的印度儿童中的溶酶体贮积症
Indian Pediatr. 2015 Dec;52(12):1029-33. doi: 10.1007/s13312-015-0768-x.
10
[Mucolipidosis: clinical and genetic aspects].[黏脂贮积症:临床与遗传学方面]
Rev Neurol. 1998 Aug;27(156):337-41.

引用本文的文献

1
Clinical and molecular characteristics of 20 Chinese probands with Mucolipidosis type II and III alpha/beta.20例II型和III型α/β型黏脂贮积症中国先证者的临床和分子特征
BMC Pediatr. 2024 Dec 23;24(1):830. doi: 10.1186/s12887-024-05223-x.
2
Burden of rare genetic disorders in India: twenty-two years' experience of a tertiary centre.印度罕见遗传疾病的负担:一家三级中心的二十二年经验。
Orphanet J Rare Dis. 2024 Aug 13;19(1):295. doi: 10.1186/s13023-024-03300-z.
3
Lysosomal storage disorders identified in adult population from India: Experience of a tertiary genetic centre and review of literature.
印度成年人群中鉴定出的溶酶体贮积症:一家三级遗传中心的经验及文献综述
JIMD Rep. 2024 Jan 2;65(2):85-101. doi: 10.1002/jmd2.12407. eCollection 2024 Mar.
4
Lysosomal storage disorders: from biology to the clinic with reference to India.溶酶体贮积症:结合印度情况从生物学进展到临床应用
Lancet Reg Health Southeast Asia. 2022 Nov 21;9:100108. doi: 10.1016/j.lansea.2022.100108. eCollection 2023 Feb.
5
Evaluation of recurrent , , and variants associated with stuttering.评估与口吃相关的复发性、 、 变体。 (注:原文中部分内容缺失,翻译可能会存在一定局限性。)
Adv Genet (Hoboken). 2021 May 20;2(2):e10043. doi: 10.1002/ggn2.10043. eCollection 2021 Jun.
6
Mucopolysaccharidoses diagnosis in the era of enzyme replacement therapy in Egypt.埃及酶替代疗法时代的黏多糖贮积症诊断
Heliyon. 2021 Aug 19;7(8):e07830. doi: 10.1016/j.heliyon.2021.e07830. eCollection 2021 Aug.
7
GNPTAB c.2404C > T nonsense mutation in a patient with mucolipidosis III alpha/beta: a case report.黏脂贮积症 III α/β 型患者中 GNPTAB 基因 c.2404C>T 无义突变:病例报告
BMC Med Genet. 2018 Sep 12;19(1):162. doi: 10.1186/s12881-018-0679-5.
8
I Cell Disease (Mucolipidosis II Alpha/Beta): From Screening to Molecular Diagnosis.I型细胞病(黏脂贮积症II型α/β型):从筛查到分子诊断
Indian J Pediatr. 2017 Feb;84(2):144-146. doi: 10.1007/s12098-016-2243-7. Epub 2016 Oct 27.
9
Burden of lysosomal storage disorders in India: experience of 387 affected children from a single diagnostic facility.印度溶酶体贮积症的负担:来自单一诊断机构的387名患病儿童的情况
JIMD Rep. 2014;12:51-63. doi: 10.1007/8904_2013_244. Epub 2013 Jul 13.